Monitor the over-allotment option exercise within 45 days; full exercise would add ~$0.84M gross proceeds. Watch for Q4 2026 operating metrics to assess whether the cash infusion extends the runway sufficiently to reach cash-flow breakeven.
Price Chart
Executive Summary
CitroTech Inc. completed a $5.6 million underwritten public offering of 2,240,000 shares at $2.50/share, with an additional 336,000-share over-allotment option. Net proceeds are earmarked for working capital and general corporate purposes. The dilutive capital raise signals near-term cash needs but extends the company's runway.
Key Financial Metrics
Key Facts
- Priced and closed a public offering of 2,240,000 shares of common stock at $2.50 per share on October 21-22, 2026.
- Aggregate gross proceeds were approximately $5.6 million before underwriting discounts and expenses.
- Underwriters received a 7.0% underwriting discount and up to $50,000 in expense reimbursement.
- Underwriters have a 45-day option to purchase up to 336,000 additional shares (15% over-allotment).
- Proceeds will be used for working capital and general corporate purposes.
- 90-day lock-up agreements were executed with officers, directors, and 5% holders.
- Shares are listed on NYSE American under ticker CITR.
Financial Impact
Dilutive equity raise of ~$5.6M gross proceeds; 2.24M new shares issued (plus up to 336K more via over-allotment).
Risk Factors
- Immediate dilution of ~12-15% to existing shareholders from the 2.24M new shares.
- Further dilution if the 336K over-allotment option is fully exercised.
- No disclosed revenue or profitability metrics — the offering suggests the company is pre-revenue or cash-flow negative.
- Use of proceeds for 'working capital and general corporate purposes' is vague and signals no near-term catalyst.
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-008023 |
| Document: citro_8k.htm | 0001683168-26-008023 |
| Document: citrotech_ex9901.htm | 0001683168-26-008023 |
| Document: citrotech_ex9902.htm | 0001683168-26-008023 |
| Document: 0001683168-26-008023-index-headers.html | 0001683168-26-008023 |
| Document: 0001683168-26-008023-index.html | 0001683168-26-008023 |
| Document: 0001683168-26-008023.txt | 0001683168-26-008023 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $2.65 | awaiting T+20 | — | $2.64 (+0.38%) |
Oct 22, 2026 4d ago | 424B4 | $2.65 | awaiting T+20 | — | $2.64 (+0.38%) |
Oct 21, 2026 6d ago | EFFECT | $2.64 | awaiting T+20 | — | $2.64 (+0.00%) |
Sep 28, 2026 28d ago | S-1 | $3.80 $2.64 | ▲ +30.53% | ▲ +30.50% | $2.64 (+30.53%) |
Sep 22, 2026 4w ago | Institutional Cluster | $4.60 $2.60 | ▼ −43.48% | ▼ −42.92% | $2.64 (−42.61%) |
Aug 10, 2026 11w ago | 10-Q/A | $5.84 $5.03 | ▲ +13.87% | ▲ +12.96% | $2.64 (+54.79%) |
Jun 17, 2026 18w ago | 8-K | $7.04 $4.71 | ▼ −33.10% | ▼ −33.63% | $2.64 (−62.50%) |
Jun 1, 2026 21w ago | 8-K | $6.92 $5.77 | ▼ −16.62% | ▼ −15.05% | $2.64 (−61.85%) |
Apr 21, 2026 26w ago | 8-K | $8.00 $6.55 | ▼ −18.13% | ▼ −23.04% | $2.64 (−67.00%) |
Apr 15, 2026 27w ago | EFFECT | $8.40 $6.83 | ▲ +18.69% | ▲ +24.73% | $2.64 (+68.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers